Fasoracetam
Limited data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- 1 ROA with full dose ladder
- duration data present
- classified Tentative
- classified Research-chemical
- 1 source
- 1 ROA with full dose ladder
- duration data present
- classified Tentative
- classified Research-chemical
Summary
A substance in the racetam family. Appears to be a GABA(B) agonist, and has shown to block memory disruptions caused by Baclofen, another GABA(B) Agonist. Similar to another compound in the racetam family Coluracetam, it enhances High affinity choline reuptake (HACU).
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 2.5-5mg | 5-10mg | 10-25mg | 25mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Total |
|---|---|---|---|
| Oral | 10-45 min | 4-8 hrs | 4-8 hrs |
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session β the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Effects
Effect glossary — · full glossary
Helpful Links
Add to PsychonautWiki Journal
The PsychonautWiki Journal logging app doesn't include every substance. To track Fasoracetam there, start adding an ingestion, search for the name, and choose to add it as a custom substance. Paste these values:
Fasoracetam Source: SubstanceSearch (substancesearch.com) Oral dose (mg): light 2.5-5 Β· common 5-10 Β· strong 10-25 Β· heavy 25+ Oral duration: onset 10-45m Β· peak 4-8h Β· total 4-8h Β· after-effects 1-6h Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.
Tip: for quicker logging you can also add a Custom Unit in the app, e.g. common dose ~ 7.5 mg (Oral).
The app keeps custom substances simple, so the full dose ranges live in the description text above. Ranges are harm-reduction guidance, not a prescription.
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for Fasoracetam? Let us know. Reports are reviewed by moderators — this is not posted publicly.